Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 1986; Volume 237,Issue 2
  • You have access
    Inhibition of guinea-pig oxyntic cell function by adenosine and prostaglandins.
    A A Heldsinger, A I Vinik and I H Fox
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 351-356;
  • You have access
    Antagonism of the final common pathway of mast cell histamine secretion by arylalkylamines.
    G W Read and D Lagunoff
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 357-363;
  • You have access
    Norepinephrine-sensitive, phenoxybenzamine-resistant receptor sites associated with contraction in rabbit arterial but not venous smooth muscle: possible role in adrenergic neurotransmission.
    I Laher, M A Khayal and J A Bevan
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 364-368;
  • You have access
    Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
    K A Cunningham and J B Appel
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 369-377;
  • You have access
    Structural modifications of pro-opiomelanocortin-derived peptides alter their behavioral effects markedly.
    M D Hirsch and T L O'Donohue
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 378-385;
  • You have access
    Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
    W Koek, J H Woods, A E Jacobson, K C Rice and R A Lessor
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 386-392;
  • You have access
    Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
    N A Ator and R R Griffiths
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 393-403;
  • You have access
    Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    L B Katz, C K Scott and D A Shriver
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 404-410;
  • You have access
    [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    M Watson, H I Yamamura and W R Roeske
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 411-418;
  • You have access
    [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    M Watson, W R Roeske and H I Yamamura
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 419-427;
  • You have access
    Central opioid receptors and baroreflex control of sympathetic and cardiovascular function.
    F J Gordon
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 428-436;
  • You have access
    Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    S E DeRossett and S G Holtzman
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 437-444;
  • You have access
    Stereoselective behavioral effects of the isomers of pentobarbital and secobarbital in the pigeon.
    G R Wenger, J M Donald and H C Cunny
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 445-449;
  • You have access
    Xylazine emesis, yohimbine and motion sickness susceptibility in the cat.
    J B Lucot and G H Crampton
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 450-455;
  • You have access
    Cellular toxicity of bromobenzene and bromobenzene metabolites to rabbit proximal tubules: the role and mechanism of 2-bromohydroquinone.
    R G Schnellmann and L J Mandel
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 456-461;
  • You have access
    Benzodiazepine dependence in mice after ingestion of drug-containing food pellets.
    E J Gallaher, S A Henauer, C J Jacques and L E Hollister
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 462-467;
  • You have access
    Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice.
    R A Ulloque, A Y Chweh and E A Swinyard
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 468-472;
  • You have access
    Thromboxane agonist (U46619) potentiates norepinephrine efflux from adrenergic nerves.
    G J Trachte
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 473-477;
  • You have access
    GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures.
    G D Frye, T J McCown, G R Breese and S L Peterson
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 478-485;
  • You have access
    Effect of ethosuximide alone and in combination with gamma-aminobutyric acid receptor agonists on brain gamma-aminobutyric acid concentration, anticonvulsant activity and neurotoxicity in mice.
    E Lin-Michell, A Y Chweh and E A Swinyard
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 486-489;
  • You have access
    Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
    S Durham and M Vore
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 490-495;
  • You have access
    Inhibition of amino acid transport by nonsteroidal anti-inflammatory drugs: a model for predicting relative therapeutic potency.
    G F Seng and B M Bayer
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 496-503;
  • You have access
    Two bradykinin binding sites with picomolar affinities.
    D C Manning, R Vavrek, J M Stewart and S H Snyder
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 504-512;
  • You have access
    Prostaglandin E2 inhibition of secretagogue-stimulated [14C]aminopyrine accumulation in rat parietal cells: a model for its mechanism of action.
    G C Rosenfeld
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 513-518;
  • You have access
    Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.
    J F Newton, D Hoefle, M W Gemborys, G H Mudge and J B Hook
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 519-524;
  • You have access
    Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
    M Panzenbeck, A Baez and G Kaley
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 525-528;
  • You have access
    Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    W Martin, R F Furchgott, G M Villani and D Jothianandan
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 529-538;
  • You have access
    Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.
    W Martin, R F Furchgott, G M Villani and D Jothianandan
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 539-547;
  • You have access
    Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    R A Cohen
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 548-552;
  • You have access
    Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
    J Goering and B G Zimmerman
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 553-557;
  • You have access
    Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
    C K Buckner, R D Krell, R B Laravuso, D B Coursin, P R Bernstein and J A Will
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 558-562;
  • You have access
    Inhibition of high-affinity choline uptake in the rat hippocampus by in vivo injection of phenobarbital in the medial septum.
    J A Richter and J M Gormley
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 563-568;
  • You have access
    Effects of secretagogues on ATP levels and protein carboxyl methylation in rat brain synaptosomes.
    J M Bjorndahl and C O Rutledge
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 569-576;
  • You have access
    Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
    D W Gil and B B Wolfe
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 577-582;
  • You have access
    Pharmacokinetics of melphalan in isolated perfusion of the limbs.
    C Benckhuijsen, F J Varossieau, A A Hart, J Wieberdink and J Noordhoek
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 583-588;
  • You have access
    Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
    B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;
  • You have access
    Halothane-cooling contractures of mammalian muscles.
    R T Sudo, M R Souza, G Zapata and G Suarez-Kurtz
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 600-607;
  • You have access
    Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
    J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu and G S Marks
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 608-614;
  • You have access
    Development and application of a specific radioimmunoassay for trifluoperazine N4'-oxide to a kinetic study in humans.
    M Aravagiri, E M Hawes and K K Midha
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 615-622;
  • You have access
    Furosemide pharmacodynamics: effect of respiratory and acid-base disturbances.
    R Babini and P du Souich
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 623-628;
  • You have access
    Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
    B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 629-635;
  • You have access
    Competition of organic anions for furosemide and p-aminohippurate secretion in the rabbit.
    J Bidiville and F Roch-Ramel
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 636-643;
  • You have access
    Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
    M Raiteri, G Maura, G Bonanno and A Pittaluga
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 644-648;
  • You have access
    Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;
  • You have access
    Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
    B Scatton, Y Claustre, T Dennis and T Nishikawa
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 659-665;
  • You have access
    Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
    M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;
  • You have access
    Extracellular calcium-dependent and -independent effects of methylmercury on spontaneous and potassium-evoked release of acetylcholine at the neuromuscular junction.
    W D Atchison
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 672-680;
  • You have access
    Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
    R Sircar, R Nichtenhauser, J R Ieni and S R Zukin
    Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 681-688;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 237, Issue 2
1 May 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics